| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |